xAnts

Breakthrough Study: Ozempic and GLP-1 Drugs Reduce Risk of 42 Health Conditions, Including Heart Attacks and Alzheimer's

In a groundbreaking study featuring nearly 2 million patients, researchers have discovered that Ozempic and GLP-1 receptor agonists significantly lower the risk of 42 health conditions, including heart attacks, Alzheimer's disease, and other serious ...Read more